ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

BLUE bluebird bio Inc

0.9399
0.0274 (3.00%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
bluebird bio Inc BLUE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0274 3.00% 0.9399 23:00:10
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.9102 0.893 0.9458 0.9228 0.9125
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202415:05BWbluebird bio Announces Receipt of Expected Notice from..
26/4/202404:45PRNUSBLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird..
19/4/202404:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
16/4/202404:45PRNUSClass Action Filed Against bluebird bio, Inc. (BLUE) Seeking..
12/4/202404:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
11/4/202407:00BWbluebird bio Reports Inducement Grants Under Nasdaq Listing..
09/4/202404:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
05/4/202404:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
26/3/202406:01BWbluebird bio Reports Fourth Quarter and 2023 Annual Results..
25/3/202415:05BWbluebird bio to Host Fourth Quarter and 2023 Annual Results..
18/3/202407:00BWbluebird bio Secures up to $175 Million Debt Financing with..
11/3/202407:00BWbluebird bio Announces First Outcomes-Based Agreement with..
05/3/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202412:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202407:03EDGAR2Form 8-K - Current report
08/1/202407:00BWbluebird bio Provides Update on Commercial Launch Progress,..
04/1/202407:00EDGAR2Form 8-K - Current report
02/1/202407:00BWbluebird bio to Present at the 42nd Annual J.P. Morgan..
20/12/202316:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202306:42EDGAR2Form 8-K - Current report
19/12/202320:41BWbluebird bio, Inc. Announces Pricing of $125 Million Public..
19/12/202305:10IHMARKETNEWSGoogle $700M Antitrust Settlement, TSMC Chairman Retirement,..
18/12/202316:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/12/202315:48EDGAR2Form 8-K - Current report
18/12/202315:01BWbluebird bio, Inc. Announces Proposed Public Offering of..
14/12/202306:30EDGAR2Form 8-K - Current report
11/12/202307:06EDGAR2Form 8-K - Current report
10/12/202311:02BWLong-Term Data Presented at ASH Support beti-cel as a..
09/12/202310:31BWLong-term Follow-up Data From bluebird’s Gene Therapy..
08/12/202315:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202315:11DJNBluebird Bio Shares Slide 41% on Black-Box Label, Higher..
08/12/202312:01BWbluebird bio Details Plans for the Commercial Launch of..
08/12/202311:35BWbluebird bio Announces FDA Approval of LYFGENIA™..
08/12/202311:03DJNBluebird Bio Gets FDA OK of Lyfgenia Gene Therapy in..
07/11/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:01EDGAR2Form 8-K - Current report
07/11/202306:00BWbluebird bio Reports Third Quarter 2023 Financial Results..
03/11/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202308:37BWbluebird bio to Present New and Updated Data from Gene..

Su Consulta Reciente

Delayed Upgrade Clock